Schedule 13D ownership disclosure

Day One Biopharmaceuticals Inc

Security class unavailable · CUSIP: 23954D109

Event date: 2021-06-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-187793
Form type
SC 13D
Filer
Canaan XI L.P.
CIK
CIK 1712417
Filed
Jun 10, 2021
Reporting period
Jun 01, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub